Research Article

Study on the Clinical Implications of NLR and PLR for Diagnosing Frailty in Maintenance Hemodialysis Patients and Their Correlations with Patient Prognosis

Table 1

Comparison of related influencing factors of frailty in patients with 1MHD.

CategoriesFrailty group (n = 72)Nonfrailty group (n = 113)χ2/t/Z value

Male (n (%))31 (43.06)57 (50.44)0.9620.327
Age (years)59.4 ± 13.753.2 ± 13.93.2610.001
Dialysis duration (months)66.94 (35.12, 88.72)67.22 (34.21, 86.23)0.5730.632
Education years8.65 ± 2.678.94 ± 2.860.5820.552
Dialysis adequacy1.43 ± 0.261.66 ± 0.275.726<0.001
Type 2 diabetes mellitus (n (%))28 (38.89)31 (27.43)2.6570.103
Coronary artery disease (n (%))14 (19.44)19 (16.81)0.2080.649
SA (g/L)37.16 ± 4.0140.41 ± 3.256.058<0.001
Hemoglobin (g/L)107.62 ± 19.81112.14 ± 15.471.7340.085
Predialysis blood urea nitrogen (mmol/L)25.74 ± 7.2526.78 ± 7.360.9430.347
Predialysis serum creatinine (umol/L)583.82 (252.34, 762.12)629.72 (272.67, 782.45)1.4320.156
Uric acid (umol/L)463.24 ± 74.59446.87 ± 71.261.4960.136
Triglyceride (mmol/L)1.71 (1.17, 2.34)1.84 (1.12, 2.19)0.6750.485
Total cholesterol (mmol/L)3.84 ± 0.793.92 ± 0.730.4510.704
High-density lipoprotein (mmol/L)1.01 ± 0.331.09 ± 0.361.5220.130
Low-density lipoprotein (mmol/L)3.38 ± 0.743.42 ± 0.710.3680.714
Blood potassium (mmol/L)4.74 ± 0.784.52 ± 0.741.9300.055
Blood calcium (mmol/L)2.04 ± 0.212.07 ± 0.230.8940.372
Blood phosphorus (mmol/L)1.92 ± 0.481.85 ± 0.490.9550.341
NLR4.18 ± 1.022.55 ± 0.9511.091<0.001
PLR129.96 ± 12.62112.62 ± 13.368.787<0.001
Body mass index (kg/m2)20.26 ± 2.5821.01 ± 2.761.8230.07
GS (kg)20.11(14.32, 21.21)28.72 (19.21, 36.72)4.785<0.001
WS (m/s)0.65 ± 0.260.76 ± 0.252.9210.004
Bicep’s circumference (mm)28.62 ± 2.3129.11 ± 3.241.1150.126
MAMC (mm)21.62 ± 2.7423.08 ± 2.723.548<0.001

SA, serum albumin; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; GS, grip strength; WS, walking speed; MAMC, midarm muscle circumference.